anmelden
25 € WM-Startbonus auf dein Cash-Konto
SXI Life Sciences
7.772,36
PKT
-3,32
PKT
-0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 25.02.20 | Novartis buy | Jefferies & Company Inc. | |
| 25.02.20 | Novartis Neutral | UBS AG | |
| 20.02.20 | Roche overweight | Barclays Capital | |
| 20.02.20 | Roche buy | Goldman Sachs Group Inc. | |
| 18.02.20 | Roche overweight | Morgan Stanley | |
| 10.02.20 | Roche buy | Jefferies & Company Inc. | |
| 07.02.20 | Roche buy | UBS AG | |
| 06.02.20 | Roche overweight | JP Morgan Chase & Co. | |
| 04.02.20 | Roche buy | Deutsche Bank AG | |
| 03.02.20 | Roche overweight | JP Morgan Chase & Co. | |
| 31.01.20 | Roche Neutral | Credit Suisse Group | |
| 31.01.20 | Novartis Hold | Deutsche Bank AG | |
| 31.01.20 | Roche buy | Deutsche Bank AG | |
| 30.01.20 | Novartis Neutral | Credit Suisse Group | |
| 30.01.20 | Roche overweight | Barclays Capital | |
| 30.01.20 | Roche buy | UBS AG | |
| 30.01.20 | Roche buy | Goldman Sachs Group Inc. | |
| 30.01.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 30.01.20 | Roche overweight | JP Morgan Chase & Co. | |
| 29.01.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 29.01.20 | Novartis Neutral | UBS AG | |
| 29.01.20 | Novartis Hold | Kepler Cheuvreux | |
| 29.01.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 27.01.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.01.20 | Roche buy | Goldman Sachs Group Inc. | |
| 27.01.20 | Roche buy | Deutsche Bank AG | |
| 24.01.20 | Roche buy | Goldman Sachs Group Inc. | |
| 23.01.20 | Roche buy | Goldman Sachs Group Inc. | |
| 23.01.20 | Roche overweight | JP Morgan Chase & Co. | |
| 22.01.20 | Roche buy | Jefferies & Company Inc. | |
| 21.01.20 | Roche buy | Merrill Lynch & Co., Inc. | |
| 20.01.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 20.01.20 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 16.01.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 16.01.20 | Novartis Underweight | Barclays Capital | |
| 16.01.20 | Roche overweight | Barclays Capital | |
| 16.01.20 | Roche Neutral | Credit Suisse Group | |
| 16.01.20 | Novartis Neutral | Credit Suisse Group | |
| 10.01.20 | Roche buy | UBS AG | |
| 09.01.20 | Roche buy | Deutsche Bank AG |